how to explain the 'watch-and-wait' period to a cll patient?
Published 7 years ago • 424 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
1:13
factors to consider when selecting between continuous and fixed-duration therapy in cll
-
1:09
cll treatment: discussing new data from the last 3 years
-
1:31
novel approaches to cll treatment
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
1:11
making clinical decisions with patients
-
2:56
short animation about cll diagnosis and the 'watch and wait' period
-
2:18
what happens during cll “watch and wait”?
-
2:02
key questions about the future of cll
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
4:25
cll: state of the art in italy
-
1:51
understanding and overcoming resistance mechanisms to novel agents used in cll
-
1:58
the future role of mrd measurement in cll
-
3:06
cll: the green study
-
4:38
venice i: venetoclax in r/r cll patients
-
2:50
elucidating and detecting mechanisms of resistance in cll
-
2:08
choosing between continuous versus fixed-duration therapy in cll
-
2:16
the role of covalent btkis in the management of cll
-
0:44
watch and wait